A transaminase mutant and application thereof in preparation of sitagliptin intermediates
US-2022396816-A1 · Dec 15, 2022 · US
Zhejiang yongtai pharmaceutical co ltd was listed as an assignee on 1 patent publication in 2022.
| Metric | Value |
|---|---|
| Company | Zhejiang yongtai pharmaceutical co ltd |
| Year | 2022 |
| Patents | 1 |
Representative publications for Zhejiang yongtai pharmaceutical co ltd in 2022.
Most common classification codes for Zhejiang yongtai pharmaceutical co ltd in 2022.
| CPC | Patents |
|---|---|
| C12N1/20 | 1 |
| C12N15/70 | 1 |
| C12N2800/101 | 1 |
| C12N9/1096 | 1 |
| C12P13/001 | 1 |
Navigate to parent entity pages.